Skip to main content

Early Symptoms of Lung Cancer

Knowing and understanding the early symptoms of lung cancer is one of the most important things that those who are at risk for the disease can do. Lung cancer is the most treatable when it is discovered early, and the only way to discover it early enough is to recognize and report the early symptoms of lung cancer. If you are noticing a combination of these lung cancer symptoms, be sure to talk to your doctor.

One of the early symptoms of lung cancer is a nagging cough that simply will not get better. Often the cough worsens with time and is accompanied by chronic chest pain. Coughing up blood is another of the many early symptoms of lung cancer. In fact, coughing up blood is one of the biggest symptoms that sends lung cancer patients to their doctors. Recurring bronchitis or pneumonia sometimes indicates that the disease is present. Fatigue and shortness of breath are more symptoms to watch out for if you suspect the disease. No matter what the symptoms are, if you have lung cancer, they will gradually progress in intensity as the disease progresses.

These lung cancer symptoms do not always indicate that the disease is present. There are other far less dangerous conditions that can cause these symptoms. However, ignoring the symptoms is dangerous, because if they are pointing to lung cancer, the disease will continue to progress. Early treatment is the best way to successfully fight lung cancer, so do not ignore these symptoms.
Labels:

Popular posts from this blog

Lung cancer survival rate - Stage 2 lung cancer

When a person looks for a medical professional about the stage 2 lung cancer, one of the first questions that come to mind is: what is my lung cancer survival rate? This is largely influenced by the medical records showing that lung cancer is one of the lowest chances of survival of cancers in the world. One must realize that these statistics are only numbers and a variety of factors that can affect your chances of being cured. The lung cancer survival rate is affected by several variables. One such variable is age. Younger people tend to have a greater chance of survival for people over 50. This is due to the strong natural defenses younger than the older. Medical records also indicate that women with lung cancer in stage 2 have a greater ability to be cured of their male counterparts the parties. The spread of malignant tumor is a very important factor in determining the survival of lung cancer exchange rate. The tumors may spread from the lung tissu...
Read more

Analysis: Life saving lung cancer test to set off cost debate

By Bill Berkrot NEW YORK | Wed Jun 29, 2011 6:07pm EDT NEW YORK (Reuters) - A landmark study showing that routine lung screening of heavy smokers and former smokers using low dose CT scans could save thousands of lives is sure to set off a fierce debate about the cost of such testing on an overburdened healthcare system. The U.S. National Cancer Institute studied more than 53,000 people between the ages of 55 and 74 deemed at high risk of developing lung cancer. It found that screening with the three-dimensional X-rays cut deaths by 20 percent. Details of the study and a discussion of its implications were published on Wednesday in the New England Journal of Medicine, lending additional weight to initial findings that were released in November. The discussion noted that radiologists using more advanced CT equipment than was available for the study could lead to an even larger reduction in lung cancer deaths. At the same time, the potential for many more false positive results could ri...
Read more

Alternative Pain Therapy for Breast, Prostate and Lung Cancer

Alternative Pain Therapy for Breast, Prostate and Lung Cancer MIAMI--(Healthcare Sales & Marketing Network)-- Bio-Nucleonics? lead product Strontium Chloride Sr-89 Injection USP (Strontium-89), which is the generic version of Metastron?, is an option to consider for metastatic cancer bone pain therapy, typically caused by advanced stage breast, prostate or lung cancer. Strontium Chloride Sr-89 Injection USP (Strontium-89) is a radioactive pharmaceutical injection to relieve bone pain in patients with painful skeletal metastases. In the body, Strontium acts similar to calcium and is preferentially taken up in osteoblastic tissue while the unabsorbed isotope is excreted in the urine the first 2 to 3 days following injection, clearing rapidly from the blood and selectively localizing in bone mineral. Uptake of strontium by bone occurs preferentially in sites of active osteogenesis; thus primary bone tumors and areas of metastatic involvement (blastic lesions) can accumulate significa...
Read more